No Data
No Data
BioPharma Credit to Provide Additional Funding to LumiraDx Amid Roche Deal
Roche, LumiraDx Deal Probed by U.K. Competition Watchdog
Express News | Cma Announced Launch of Its Merger Inquiry on Roche/Lumiradx by Notice to Parties on 23 May 2024 and Has a Deadline of 19 July 2024 for Its Phase 1 Decision
Express News | Competitiona and Market Authority: Says Start of Cma Merger Investigation: Roche / Lumiradx
CMA Invites Views From Interested Parties On Roche, LumiraDx Deal
U.K. Competition Watchdog Weighs Potential Impact of Roche-LumiraDx
No Data
No Data